GE Healthcare and NIBRT Join Forces to Boost Talent Growth in Single-Use Bioprocessing

Marlborough, MA, United States and Dublin, Ireland – GE Healthcare (GEHC) and the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin, Ireland are combining their expertise to deliver educational programming on biopharmaceutical and cell therapy development and manufacturing. As part of the collaboration, GE Healthcare and NIBRT will share programming, including GE Healthcare’s Fast Trak training and [...]

Arcline Investment Management Acquires Majority Interest In Cell And Gene Therapy Materials Supplier Akron Biotechnology

BOCA RATON, FLORIDA—Arcline Investment Management ("Arcline"), a growth oriented private equity firm with $1.5 billion of capital under management, today announced that it has acquired a majority interest in Akron Biotechnology LLC ("Akron" or "The Company"). Akron will continue to be led by Claudia Zylberberg, PhD, the Company's founder and CEO and a member of [...]

BIA Separations Introduces Cornerstone AAV Process Development Service to Accelerate Gene Therapy Production

CORNERSTONE program integrates process development expertise and novel technology to remove development bottlenecks in the manufacture of Gene Therapy Medicinal Products (GTMPs). Portfolio includes novel CIMasphere™ technology for higher yielding processes and safer products in AAV-based programs BIA Separations, a leading bio-chromatography development and manufacturing company, today announced the introduction of CORNERSTONE AAV Process Development Service, [...]

NanoView Biosciences and Quantum Design Korea Enter Into Distribution Agreement

BOSTON -- NanoView Biosciences, Inc., and Quantum Design Korea, a subsidiary of Quantum Design International, today announced an exclusive distribution agreement for NanoView’s ExoView™ platform in South Korea. “We are eager to make NanoView’s unique technology for analyzing and characterizing exosomes available to scientists in Korea,” said Manwoong Nam, General Manager of Quantum Design Korea. [...]

Bio-Rad Files New Lawsuit Against 10X Genomics for Patent Infringement

HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has filed a patent infringement suit against 10X Genomics, Inc. in the United States District Court for the District of Delaware. In the lawsuit Bio-Rad asserts that 10X Genomics infringes U.S. Patent [...]

Orion Pharmaceuticals Implements Genedata Biologics to Support New Large-Molecule R&D Initiative

Genedata Biologics to accelerate antibody discovery and streamline R&D operations at Finland’s largest biopharma company Basel, Switzerland – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced Orion Pharma, a globally operating Finnish pharmaceutical company, has licensed Genedata Biologics® to support their R&D in the areas of oncology, the central nervous [...]

Bruker Launches Nanoscale Infrared Spectroscopy and Chemical Imaging SNOM/AFM Microscopy System with Broadband Femtosecond IR Laser

Most Advanced s-Scanning Near-field Optical Microscopy/Atomic Force Microscopy-IR System Commercially Available AMSTERDAM -- At the 4th Annual European Forum on Nanoscale IR Spectroscopy, Bruker (Nasdaq: BRKR) today announced the release of the nanoIR3-s Broadband™, the most advanced nanoscale FTIR spectroscopy system available to researchers. The system combines Bruker's industry-leading, high-performance, nanoIR3-s s-SNOM (scattering Scanning Near-field Optical Microscopy) based platform with [...]

Mark Beaudouin to Retire as Waters General Counsel; Company Promotes Keeley Aleman

MILFORD, Mass.--Waters Corporation (NYSE: WAT) today announced Mark T. Beaudouin is retiring as Senior Vice President, General Counsel and Corporate Secretary after 16 years leading the Company’s legal team. Current Vice President, Deputy General Counsel and Assistant Secretary, Keeley A. Aleman, will be promoted to Senior Vice President, General Counsel and Corporate Secretary, and a member of the Executive [...]

InDevR Raises $7 Million in Series A Financing With Adjuvant Capital

BOULDER, Colo. -- InDevR, Inc., a biotechnology company focused on developing and commercializing novel analytical technologies for biologic process development and monitoring, today announced that it has raised a $7 million Series A round of equity financing from Adjuvant Capital ("Adjuvant"). The investment from Adjuvant will support research and development activities and allow InDevR to build out a global [...]

BioDiscovery Designates Children’s Hospital of Los Angeles as a Center of Excellence for Clinical Genomics

El Segundo, CA – BioDiscovery, Inc., a leader in innovative genomic software solutions, announced that Children’s Hospital of Los Angeles (CHLA), an award-winning hospital with comprehensive medical care services and programs for children, has signed on as a BioDiscovery Center of Excellence for Clinical Genomics to serve as a reference site for others seeking information [...]

Access IBO on Knowledge Center